Published in Zh Mikrobiol Epidemiol Immunobiol on March 14, 2006
DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol (2006) 0.94
Amyloidogenic peptide homologous to beta-domain region of alpha-lactalbumin. Dokl Biochem Biophys (2007) 0.89
Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) (2012) 0.88
Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein. Tuberculosis (Edinb) (2006) 0.84
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus. Mol Cell Probes (1990) 0.82
[Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics]. Mol Biol (Mosk) (2009) 0.81
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
Atomic force microscopy study of peptides homologous to beta-domain of alpha-lactalbumins. Protein Pept Lett (2007) 0.81
[Etiological characteristics of the influenza epidemics of 2006-2009 in the Russian Federation (according to the data of the Research Institute of Influenza, North-Western Branch, Russian Academy of Medical Sciences)]. Vopr Virusol (2010) 0.81
[Antiviral activity of several vasodilator agents]. Biull Eksp Biol Med (1996) 0.81
Recombinant influenza vaccines. Acta Naturae (2012) 0.80
DNA sequencing with thermostable Tet DNA polymerase from Thermus thermophilus. Nucleic Acids Res (1989) 0.80
[Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin]. Mol Biol (Mosk) (1995) 0.79
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
[Endogenous phosphorylation of sarcoplasmic reticulum fragments of rabbit fast skeletal muscles]. Biokhimiia (1982) 0.79
[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses]. Vopr Virusol (2014) 0.78
[Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection]. Biull Eksp Biol Med (1992) 0.78
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models]. Vopr Virusol (2010) 0.78
[In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus]. Vopr Virusol (2011) 0.77
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein. Acta Naturae (2010) 0.77
[Effect of different water-soluble forms of the fullerene C60 on the metabolic activity and ultra-structure of cells in culture]. Biofizika (2012) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
[Study of tolerability and reactogenicity of pandemic vaccines against influenza type A/H1N1]. Zh Mikrobiol Epidemiol Immunobiol (2010) 0.77
[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]. Antibiot Khimioter (2010) 0.77
[Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice]. Antibiot Khimioter (2010) 0.77
[Experimental study of Ingavirin antiviral activity against human adenovirus]. Antibiot Khimioter (2010) 0.77
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia. Bull Exp Biol Med (2015) 0.76
[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76
[Universal influenza vaccines: developments, prospects for use]. Vopr Virusol (2012) 0.76
[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76
Insulin fibrillogenesis in vitro. Dokl Biochem Biophys (2008) 0.76
[Development of the anti-influenza H5N1 vaccines worldwide and in Russia]. Zh Mikrobiol Epidemiol Immunobiol (2006) 0.76
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models]. Eksp Klin Farmakol (2007) 0.75
[The effect of influenza virus hemagglutinin on erythrocytes and thrombocytes]. Izv Akad Nauk Ser Biol (1999) 0.75
[Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene]. Vopr Virusol (2012) 0.75
[H1N1V influenza epidemic of 2009 in Russia]. Vestn Ross Akad Med Nauk (2011) 0.75
[Genetic diversity and molecular evolution of the influenza A viruses in Russia during 2006-2012]. Vopr Virusol (2013) 0.75
[Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction]. Vopr Virusol (2001) 0.75
No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses. Dokl Biol Sci (2007) 0.75
[A new method of producing biologically active nanocomplexes by non-covalent conjugation of proteins with viral particles]. Bioorg Khim (2011) 0.75
[Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol (2015) 0.75
[Features of interepidemic influenza A and B viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Antiviral activity of fullerene (60)C complexed with poly(N-vinylpyrrolidone)]. Dokl Akad Nauk (1998) 0.75
[International symposium on military-civilian cooperation in surveillance and control of influenza]. Vopr Virusol (2004) 0.75
[Transformation of eucaryotic cells with complexes of plasmid DNA and polycations]. Dokl Akad Nauk (1999) 0.75
[Studying the effect of antioxidants and/or antihypoxants on cell cultures under conditions of cytotoxic action of rimantadine]. Eksp Klin Farmakol (2007) 0.75
[Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix]. Vopr Onkol (2011) 0.75
[Polymorphism of current human influenza A and B virus population]. Vestn Ross Akad Med Nauk (1994) 0.75
[Determination of nucleotide sequences of Russian isolates of delta hepatitis virus]. Mol Gen Mikrobiol Virusol (1997) 0.75
Study of protein components of natural peptide regulators. Bull Exp Biol Med (2003) 0.75
[Prevention of tuberculosis: current approaches to development of vaccines]. Vestn Ross Akad Med Nauk (2012) 0.75
[Quantitative competitive PCR--diagnostic method for monitoring cytomegalovirus infection and antiviral therapy]. Mol Biol (Mosk) (2000) 0.75
[Bird flu as a global biocatastrophe (editorial)]. Ter Arkh (2006) 0.75
[Use of liposomes for vaccines design]. Vopr Virusol (2001) 0.75
[Evaluation of metabolic parameters in vitro as a model for testing the cytotoxicity of antiviral drugs]. Eksp Klin Farmakol (2006) 0.75
[The etiological structure of the morbidity from influenza and other ARDs on the territory of Russia in the season of 1997-1998]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]. Vopr Virusol (2013) 0.75
[Clinical trial of new inactivated influenza vaccine "Grifor"]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.75
[Prognostic value of human papilloma virus DNA test in patients surgically treated for squamous cell cervical cancer]. Vopr Onkol (2012) 0.75
[Pandemic influenza 2009 in Russia. Characteristics of the isolation and biological properties of viruses]. Vopr Virusol (2011) 0.75
[Inhibiting effect of no-spa on paragrippe virus reproduction]. Biull Eksp Biol Med (1999) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[Development of novel drugs against influenza virus based on synthetic and natural compounds]. Vopr Virusol (2013) 0.75
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR]. Ter Arkh (2015) 0.75
[Pathogenesis of severe influenza]. Vestn Ross Akad Med Nauk (1994) 0.75
[Isolation and cloning of gene for hepatitis delta antigen. The use of recombinant antigen for serodiagnosis of delta infection]. Mol Gen Mikrobiol Virusol (1998) 0.75
[The role of influenza virus hemagglutinin in blood anticoagulation processes]. Vopr Virusol (1997) 0.75
[Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek (2006) 0.75
[Comparative study of the differential susceptibility of different cell lines to pandemic H1N1v influenza viruses and avian influenza, swine influenza, and human influenza viruses]. Vopr Virusol (2012) 0.75
[The use of apoptosis inducers in the therapy of experimental influenza infection and preventing of chronic post-influenza lung damage]. Tsitologiia (2014) 0.75
[Molecular bases of prion diseases]. Vestn Ross Akad Med Nauk (1998) 0.75
[ Influenza virus proteins modulate hemostasis in vitro and in vivo ]. Izv Akad Nauk Ser Biol (2004) 0.75
[Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol (2011) 0.75
[Immunosuppression at pregnancy and flu]. Vopr Virusol (2013) 0.75
[Structure and antiviral activity of adamantane-containing polymer preparation]. Vopr Virusol (2003) 0.75
[Antiviral activity of Ingavirin on an animal model for experimental disseminated adenovirus infection]. Vopr Virusol (2012) 0.75
[Usage of polymerase chain reaction in complex diagnosis of hepatitis B]. Vopr Virusol (2000) 0.75
[Deitiforine, an antiinfluenza chemotherapeutic]. Antibiot Khimioter (2013) 0.75
[Effect of Ingavirin on the ultrastructure of the morphogenesis of adenovirus infection in vivo]. Vopr Virusol (2012) 0.75
[Effect of polymer carrier origin and physical state on fullerene C60 phototoxicity in vitro]. Eksp Klin Farmakol (2011) 0.75
[Molecular-biological properties of the rubella virus strains isolated in St. Petersburg]. Mol Biol (Mosk) (2012) 0.75
[Ingavirin treatment of experimental parainfluenza pneumonia in Syrian hamsters]. Vopr Virusol (2012) 0.75
[The influence of atropine blocking of the vagus nerves on the excitability of the left ventricle in the guinea pig]. Biull Eksp Biol Med (1966) 0.75
[Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine]. Vopr Virusol (2013) 0.75